MIAMI, Jan. 24, 2014 /PRNewswire/ — NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching “Matured & Orphan Drugs,” has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug […]
Read More
Category
Category: Press Release
January 24, 2014
NextSource Biotechnology Announces FDA Short Supply release of the formally known Bristol Myers Squibb (CeeNu®) Brand Oncology product now currently marketed under the NextSource Biotechnology Lomustine (CCNU) label Exclusively in the United States
by
in
Press Release
0 comments
September 23, 2013
NextSource Biotechnology Launches New Strategic Approach to Mitigate Slow-Downs in Manufacturing of Matured Medications in High Demand
by
in
Press Release
0 comments
MIAMI, Sept. 23, 2013 /PRNewswire/ — NextSource Biotechnology, LLC., (NSB), a leading Specialty Pharmaceutical Manufacturing and Marketing company with a strategic objective of Consolidating, Re-Branding and launching a “Matured & Orphan Drugs” product portfolio in the U.S. and International Healthcare Markets. By utilizing a worldwide distribution network as a key synergistic approach to aggressively build […]
Read More